162 related articles for article (PubMed ID: 20727744)
1. Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles.
Walter M; Isensee K; Kottke T; Ligneau X; Camelin JC; Schwartz JC; Stark H
Bioorg Med Chem Lett; 2010 Oct; 20(19):5883-6. PubMed ID: 20727744
[TBL] [Abstract][Full Text] [Related]
2. Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
Walter M; von Coburg Y; Isensee K; Sander K; Ligneau X; Camelin JC; Schwartz JC; Stark H
Bioorg Med Chem Lett; 2010 Oct; 20(19):5879-82. PubMed ID: 20728354
[TBL] [Abstract][Full Text] [Related]
3. Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.
Swanson DM; Shah CR; Lord B; Morton K; Dvorak LK; Mazur C; Apodaca R; Xiao W; Boggs JD; Feinstein M; Wilson SJ; Barbier AJ; Bonaventure P; Lovenberg TW; Carruthers NI
Eur J Med Chem; 2009 Nov; 44(11):4413-25. PubMed ID: 19577344
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonists.
Shao N; Aslanian R; West RE; Williams SM; Wu RL; Hwa J; Sondey C; Lachowicz J; Palani A
Bioorg Med Chem Lett; 2012 Mar; 22(5):2075-8. PubMed ID: 22326166
[TBL] [Abstract][Full Text] [Related]
5. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
Maslowska-Lipowicz I; Figlus M; Zuiderveld OP; Walczynski K
Arch Pharm (Weinheim); 2008 Dec; 341(12):762-73. PubMed ID: 19009544
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists.
Célanire S; Wijtmans M; Christophe B; Collart P; de Esch I; Dassesse D; Delaunoy C; Denonne F; Durieu V; Gelens E; Gillard M; Lallemand B; Lamberty Y; Lebon F; Nicolas JM; Quéré L; Snip E; Vanbellinghen A; Van Houtvin N; Verbois V; Timmerman H; Talaga P; Leurs R; Provins L
ChemMedChem; 2009 Jul; 4(7):1063-8. PubMed ID: 19405064
[TBL] [Abstract][Full Text] [Related]
7. Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity.
Incerti M; Flammini L; Saccani F; Morini G; Comini M; Coruzzi M; Barocelli E; Ballabeni V; Bertoni S
ChemMedChem; 2010 Jul; 5(7):1143-9. PubMed ID: 20512794
[TBL] [Abstract][Full Text] [Related]
8. Fluorinated non-imidazole histamine H3 receptor antagonists.
Isensee K; Amon M; Garlapati A; Ligneau X; Camelin JC; Capet M; Schwartz JC; Stark H
Bioorg Med Chem Lett; 2009 Apr; 19(8):2172-5. PubMed ID: 19286376
[TBL] [Abstract][Full Text] [Related]
9. The discovery of the benzazepine class of histamine H3 receptor antagonists.
Wilson DM; Apps J; Bailey N; Bamford MJ; Beresford IJ; Briggs MA; Calver AR; Crook B; Davis RP; Davis S; Dean DK; Harris L; Heightman TD; Panchal T; Parr CA; Quashie N; Steadman JG; Schogger J; Sehmi SS; Stean TO; Takle AK; Trail BK; White T; Witherington J; Worby A; Medhurst AD
Bioorg Med Chem Lett; 2013 Dec; 23(24):6897-901. PubMed ID: 24161834
[TBL] [Abstract][Full Text] [Related]
10. Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonists.
Stocking EM; Aluisio L; Atack JR; Bonaventure P; Carruthers NI; Dugovic C; Everson A; Fraser I; Jiang X; Leung P; Lord B; Ly KS; Morton KL; Nepomuceno D; Shah CR; Shelton J; Soyode-Johnson A; Letavic MA
Bioorg Med Chem Lett; 2010 May; 20(9):2755-60. PubMed ID: 20382018
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and three-dimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group.
Rivara S; Mor M; Bordi F; Silva C; Zuliani V; Vacondio F; Morini G; Plazzi PV; Carrupt PA; Testa B
Drug Des Discov; 2003; 18(2-3):65-79. PubMed ID: 14675944
[TBL] [Abstract][Full Text] [Related]
12. Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.
Lim HD; Istyastono EP; van de Stolpe A; Romeo G; Gobbi S; Schepers M; Lahaye R; Menge WM; Zuiderveld OP; Jongejan A; Smits RA; Bakker RA; Haaksma EE; Leurs R; de Esch IJ
Bioorg Med Chem; 2009 Jun; 17(11):3987-94. PubMed ID: 19414267
[TBL] [Abstract][Full Text] [Related]
13. Amine-constrained pyridazinone histamine H₃ receptor antagonists.
Sundar BG; Bailey T; Bacon E; Aimone L; Huang Z; Lyons J; Raddatz R; Hudkins R
Bioorg Med Chem Lett; 2011 Sep; 21(18):5543-6. PubMed ID: 21824776
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists.
Zeng Q; Rosenblum SB; Yang Z; Jiang Y; McCormick KD; Aslanian RG; Duguma L; Kozlowski JA; Shih NY; Hey JA; West RE; Korfmacher WA; Berlin M; Boyce CW
Bioorg Med Chem Lett; 2013 Nov; 23(21):6001-3. PubMed ID: 24050887
[TBL] [Abstract][Full Text] [Related]
15. Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
Dvorak CA; Apodaca R; Xiao W; Jablonowski JA; Bonaventure P; Dugovic C; Shelton J; Lord B; Miller K; Dvorak LK; Lovenberg TW; Carruthers NI
Eur J Med Chem; 2009 Oct; 44(10):4098-106. PubMed ID: 19524331
[TBL] [Abstract][Full Text] [Related]
16. Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.
Sasho S; Seishi T; Kawamura M; Hirose R; Toki S; Shimada JI
Bioorg Med Chem Lett; 2008 Apr; 18(7):2288-91. PubMed ID: 18353639
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H₃ receptor antagonists.
Tao M; Raddatz R; Aimone LD; Hudkins RL
Bioorg Med Chem Lett; 2011 Oct; 21(20):6126-30. PubMed ID: 21906941
[TBL] [Abstract][Full Text] [Related]
18. Non-imidazole histamine H3 ligands, part IV: SAR of 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.
Frymarkiewicz A; Walczyński K
Eur J Med Chem; 2009 Apr; 44(4):1674-81. PubMed ID: 18990469
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel steroidal histamine H
Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Greiner I; Schmidt É; Némethy Z; Kedves RS; Balázs O; Román V; Lévay G; Mahó S
Bioorg Med Chem Lett; 2017 Oct; 27(19):4525-4530. PubMed ID: 28888822
[TBL] [Abstract][Full Text] [Related]
20. Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonists.
Cole DC; Gross JL; Comery TA; Aschmies S; Hirst WD; Kelley C; Kim JI; Kubek K; Ning X; Platt BJ; Robichaud AJ; Solvibile WR; Stock JR; Tawa G; Williams MJ; Ellingboe JW
Bioorg Med Chem Lett; 2010 Feb; 20(3):1237-40. PubMed ID: 20042333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
